Design and rationale of the drug-coated balloon coronary angioplasty versus stenting for treatment of disease adjacent to a chronic total occlusion (Co-CTO) trial
Study context
- Population
- Patients undergoing CTO percutaneous coronary intervention (PCI)planned enrolment
- Participants
- 144 patients
- Planned comparison
- Hybrid strategy vs complete stenting
- Primary endpoint
- In-segment percentage diameter stenosis by intravascular ultrasound
- Follow-up
- 1 year
Methodological detailsdesign and rationale, single-blind, non-inferiority
- Design and rationale
- Single-blind
- Non-inferiority
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
Design and rationale of the drug-coated balloon coronary angioplasty versus stenting for treatment of disease adjacent to a chronic total occlusion (Co-CTO) trial. Am Heart J. Published 7 April 2025. doi:10.
Summarised from the published abstract; every number is checked against it